A monoclonal antibody targeting the C-terminal of α-synuclein fibrils mitigates pathology in a Parkinson’s disease model
Cell Reports · 2026
DOI: 10.1016/j.celrep.2025.116897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Shuyi Zeng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong Univers…. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Antibodies, Monoclonal, Amyloid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Sciences, Shanghai Branch, Canadian Anesthesiologists' Society, National Science and Technology Major Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai 200030, China; Zhangjiang Institute for Advanced Study,…
- Interdisciplinary Research Center on Biology and Chemistry, State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
- Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai 201210, China.
- Interdisciplinary Research Center on Biology and Chemistry, State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China; University of the Chine…
- Shanghai Starriver Bilingual School, Shanghai 201108, China.
- Department of Neurology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, China.
Förderung
- Chinese Academy of Sciences, Shanghai Branch
- Canadian Anesthesiologists' Society
- National Science and Technology Major Project
- University of Science and Technology of China
- National Natural Science Foundation of China
- Dalian Medical University
- Chinese Academy of Sciences
- Shanghai Advanced Research Institute, Chinese Academy of Sciences
Zitieren
APA
Zeng, S., Zhang, S., Gui, X., Li, D., Lv, S., Dong, H., Xu, Q., Wu, J., Ren, H., Zhao, Q., Long, H., Yu, Y., Hou, S., Le, W., Fan, M., Liu, D., Li, D., & Liu, C. (2026). A monoclonal antibody targeting the C-terminal of α-synuclein fibrils mitigates pathology in a Parkinson’s disease model. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116897
Vancouver
Zeng S, Zhang S, Gui X, Li D, Lv S, Dong H, et al. A monoclonal antibody targeting the C-terminal of α-synuclein fibrils mitigates pathology in a Parkinson’s disease model. Cell Reports. 2026. doi:10.1016/j.celrep.2025.116897
BibTeX
@article{Zeng2026,
author = {Zeng, Shuyi and Zhang, Shengnan and Gui, Xun and Li, Danni and Lv, Shiran and Dong, Hui and Xu, Qianhui and Wu, Jian and Ren, Hongyuan and Zhao, Qinyue and Long, Houfang and Yu, Yifan and Hou, Shouqiao and Le, Weidong and Fan, Mengqi and Liu, Datao and Li, Dan and Liu, Cong},
title = {A monoclonal antibody targeting the C-terminal of α-synuclein fibrils mitigates pathology in a Parkinson’s disease model},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2025.116897}
}
EUVIMED